PARP Inhibitors Very Likely Work in Ovarian Cancer without BRCA1 or BRCA2 Mutations - 102134

Spotlight
Video

PARP Inhibitors Very Likely Work in Ovarian Cancer without BRCA1 or BRCA2 Mutations

SGO2017 has 36 videos Subscribe Here

Loading........
Description: Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC discusses how the use of PARP Inhibitors work for Ovarian Cancer treatment without BRCA mutations. This was recorded at the 2017 Society of Gynecologic Oncology (SGO)’s Annual Meeting on Women’s Cancer® in National Harbor, MD.
Shared By : SGO2017
Posted on : 03/21/17
Added : 2 years ago
Category : Ovarian Cancer